Julian Downward | |
|---|---|
 | |
| Born | 25 October 1960[1] |
| Employer |
|
| Website | http://crick.ac.uk/research/a-z-researchers/researchers-d-h/julian-downward/  |
| Scientific career | |
| Fields | Cancer biology[2] |
| Thesis | The structure and function of the receptor for epidermal growth factor (1986) |
| Doctoral advisor | Michael Waterfield |
| Other academic advisors | Robert Weinberg |
| Website | crick |
David Julian Harry Downward[clarification needed] (born 25 October 1960)[1] FRS FMedSci is Associate Research Director at the Francis Crick Institute and Senior Group Leader at the Institute of Cancer Research.[3] He was formerly head of the Signal transduction Laboratory at the London Research Institute.[4][5][6][2] He is a member of the Editorial Board for Cell.[7]
- ^ a b "DOWNWARD, Prof. Julian". Who's Who. Vol. 2016 (online Oxford University Press ed.). Oxford: A & C Black. (Subscription or UK public library membership required.)
- ^ a b Julian Downward publications indexed by Google Scholar
- ^ Cite error: The named reference
frswas invoked but never defined (see the help page). - ^ "Professor Julian Downward: Team Leader". London: Institute of Cancer Research. Archived from the original on 7 September 2015.
- ^ Downward, Julian (2003). "Targeting RAS signalling pathways in cancer therapy". Nature Reviews Cancer. 3 (1): 11–22. doi:10.1038/nrc969. ISSN 1474-175X. PMID 12509763. S2CID 43074411.
- ^ Castellano, E.; Downward, J. (2011). "RAS Interaction with PI3K: More Than Just Another Effector Pathway". Genes & Cancer. 2 (3): 261–274. doi:10.1177/1947601911408079. ISSN 1947-6019. PMC 3128635. PMID 21779497.
- ^ "Editorial board: Cell".